Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
- Name
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
- Accession Number
- DBCAT003282
- Description
Not Available
- Drugs
Drug Drug Description Palivizumab A monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients. Nirsevimab A long-acting monoclonal antibody indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants. - Drugs & Drug Targets